VERV Verve Therapeutics, Inc.
Biotechnology NasdaqGS
Trading Signals (VERV)
Overall Signal
BUY
Strong buyish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $10.82
- Medium Support $10.92
- Weak Support $11.03
Resistance Levels
- Weak Resistance $11.23
- Medium Resistance $11.34
- Strong Resistance $11.44
Stop Loss Suggestions
- Conservative $11.05
- Moderate $10.97
- Aggressive $10.87
Analyst Ratings
Current Rating
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | BUY |
|
Short & Medium Term |
| Oscillators | SELL |
|
Short Term |
| Trend Indicators | BUY |
|
Medium Term |
| Volume Indicators | BUY |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities (VERV)
Quarterly Outlook :
2026-11-04
Bullish Scenario
from current 24.26%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (27.41) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (69.07) is in bullish territory, indicating upward momentum. MACD line (1.43) is above Signal line (0.80) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.08, indicating the average weekly price range.
2026-11-04
Base Scenario
from current 9.7%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (27.41) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (69.07) is in bullish territory, indicating upward momentum. MACD line (1.43) is above Signal line (0.80) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.08, indicating the average weekly price range.
2026-11-04
Bearish Scenario
from current -19.41%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (27.41) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (69.07) is in bullish territory, indicating upward momentum. MACD line (1.43) is above Signal line (0.80) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.08, indicating the average weekly price range.
Annual Outlook
2026-11-04
Bullish Scenario
from current 48.52%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (27.41) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (69.07) is in bullish territory, indicating upward momentum. MACD line (1.43) is above Signal line (0.80) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.08, indicating the average weekly price range.
2026-11-04
Base Scenario
from current 19.41%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (27.41) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (69.07) is in bullish territory, indicating upward momentum. MACD line (1.43) is above Signal line (0.80) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.08, indicating the average weekly price range.
2026-11-04
Bearish Scenario
from current -38.81%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (27.41) indicates a strong trend. +DI > -DI suggests strong bullish directional bias. RSI (69.07) is in bullish territory, indicating upward momentum. MACD line (1.43) is above Signal line (0.80) (bullish crossover), confirming upward momentum. Both lines are above zero, reinforcing bullish trend. Current Weekly ATR is 1.08, indicating the average weekly price range.
Technical Analysis (VERV)
Trend Identification
EMA
Exponential Moving Average
Current price (11.13) is above both Short MA (11.11) and Long MA (7.65). This indicates strong bullish momentum. Short MA (11.11) is above Long MA (7.65), a bullish crossover ('Golden Cross' if it's a significant period). This indicates an upward trend. All MAs are in bullish order (Price > Short MA > Long MA > Very Long MA 6.66). This is a strong bullish alignment. Consider long positions. Use the MAs as dynamic support levels.
MACD
Moving Average Convergence Divergence
MACD line is below the Signal line (bearish crossover). This indicates downward momentum. Histogram (-0.2100) is negative and expanding, confirming bearish momentum. Both MACD and Signal lines are above the zero line, reinforcing bullish momentum (bullish territory). A bearish crossover above the zero line can indicate a reversal from a prior uptrend. Consider this as a potential early sell signal.
ADX
Average Directional Index
ADX (57.60) indicates a strong trend is present. +DI (42.30) is above -DI (11.23), suggesting a bullish directional bias. This combination points to a strong upward trend. Consider taking long positions, as the strong upward trend is confirmed.
Momentum Measurement
RSI (2026-11-04)
Relative Strength Index
RSI (76.29) is in the overbought zone. This suggests the asset may be due for a price correction or a trend reversal downwards. Consider profit-taking or short-selling opportunities cautiously.
OBV (2026-11-04)
On-Balance Volume
OBV (172768031.00) is rising, indicating buying pressure and accumulation. Price is rising and OBV is rising. This is bullish confirmation, indicating buying pressure supports the price increase. Consider holding long positions or initiating new ones. Volume is supporting the trend.
Stochastic (2026-11-04)
Stochastic Oscillator
Stochastics (%K: 81.85, %D: 62.08) are in the neutral zone (between 20 and 80). A bullish crossover (%K above %D) is observed. This indicates upward momentum. Be cautious if it's already in the overbought region.
CCI (2026-11-04)
Commodity Channel Index
CCI (94.50) is between 0 and +100. This indicates bullish momentum is present, but not yet extreme. A move above 0 from negative territory (bullish zero-line cross) can indicate a potential buy signal.
Volatility Measurement
ATR (2026-11-04)
Average True Range
Current ATR is 0.2300. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands (2026-11-04)
Volatility Bands
Current price (11.13) is within the Bollinger Bands (10.88 - 11.34). This suggests the price is trading within its typical volatility range. Price is above the Middle Band (11.11), indicating short-term bullish bias.
Risk Management & Potential Reversals (VERV)
SAR (2026-11-04)
Parabolic Stop and Reverse
SAR points above price indicate bearish trend. Current SAR at 11.27 is 1.26% from price. Consider SAR as a potential take-profit level or to confirm a downtrend.
Stochastic (2026-11-04)
Overbought
Stochastic is in overbought territory (81.8). Monitor for potential bearish crossover or movement below 80, which could signal a reversal. Current crossover status: Bullish.
RSI (2026-11-04)
Reversal Perspective
Current RSI level suggests overbought conditions, indicating potential for a bearish reversal. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Bollinger Bands (2026-11-04)
Reversal Perspective
Bands show normal bandwidth. Price is in the middle of bands with normal bandwidth. No indication of imminent volatility expansion or reversal.
Holder List Top 20 (VERV)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| Alphabet Inc. | INSTITUTIONAL | 12349086 | 13.85% | 2025-03-31 |
| Blackrock Inc. | INSTITUTIONAL | 7878236 | 8.84% | 2025-03-31 |
| BVF Inc. | INSTITUTIONAL | 6904050 | 7.74% | 2025-03-31 |
| Casdin Capital, LLC | INSTITUTIONAL | 3995571 | 4.48% | 2025-03-31 |
| Vanguard Group Inc | INSTITUTIONAL | 3955099 | 4.44% | 2025-03-31 |
| State Street Corporation | INSTITUTIONAL | 3091189 | 3.47% | 2025-03-31 |
| Novo Holdings A/S | INSTITUTIONAL | 3000000 | 3.37% | 2025-03-31 |
| Schonfeld Strategic Advisors Llc | INSTITUTIONAL | 2923418 | 3.28% | 2025-03-31 |
| Woodline Partners LP | INSTITUTIONAL | 2767719 | 3.1% | 2025-03-31 |
| T. Rowe Price Investment Management, Inc. | INSTITUTIONAL | 2491949 | 2.8% | 2025-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | MUTUALFUND | 2130793 | 2.39% | 2025-03-31 |
| iShares Trust-iShares Russell 2000 ETF | MUTUALFUND | 1741874 | 1.95% | 2025-04-30 |
| SPDR SERIES TRUST-SPDR(R) S&P(R) Biotech ETF | MUTUALFUND | 1345896 | 1.51% | 2025-04-30 |
| T. Rowe Price Small-Cap Value Fund, Inc. | MUTUALFUND | 1174386 | 1.32% | 2025-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | MUTUALFUND | 1052458 | 1.18% | 2025-03-31 |
| TIAA-CREF Funds-Nuveen Quant Small Cap Equity Fund | MUTUALFUND | 961000 | 1.08% | 2025-01-31 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | MUTUALFUND | 708017 | 0.79% | 2025-02-28 |
| -Price (T.Rowe) U.S. Small-Cap Value Equity Trust | MUTUALFUND | 678953 | 0.76% | 2025-03-31 |
| iShares Trust-iShares Russell 2000 Value ETF | MUTUALFUND | 674110 | 0.76% | 2025-04-30 |
| iShares Trust-iShares Biotechnology ETF | MUTUALFUND | 411454 | 0.46% | 2025-04-30 |